|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
29.760 -0.340 (-1.130%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,168,384 | 48.639% | 786,056 | 669,703 | 946,049 | 2,114,448 |
| Cost of Sales | (244,359) | 15.919% | (210,801) | (288,513) | (320,472) | (463,942) |
| Gross Profit | 924,025 | 60.629% | 575,255 | 381,190 | 625,577 | 1,650,506 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,361 | -77.333% | 10,416 | (1,122) | 41 | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (25,209) | -10.686% | (28,225) | (32,306) | (28,249) | (11,570) | |
| Profit / (Loss) before Taxation | (485,947) | -29.048% | (684,894) | (1,175,833) | (988,912) | 99,325 | |
| Taxation | 19,538 | -- | (3,551) | 50,495 | (9,448) | (88,792) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 52,978 | 23.914% | 42,754 | 128,917 | 87,031 | 1 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (413,431) | -35.971% | (645,691) | (996,421) | (911,329) | 10,534 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 25,025 | -- | (61) | (40,479) | (13,209) | 22,553 |
| Depreciation & Amortisation | -- | -- | -- | -- | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -42.000 | -36.364% | -66.000 | -101.000 | -100.000 | 1.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 6.229 | -- | 6.591 | 8.635 | 7.846 | 8.849 |
| Remarks: | Real time quote last updated: 24/09/2025 15:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -413,431 |
| %Change | -35.971% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 6.229 |